EDIT
Editas Medicine Inc
2.70$
-2.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.2% | -3.9% | +0.8% | +12.6% | -13.6% | +38.8% | -17.7% | -54.3% | +92.5% | -65.2% | -13.9% | – | |
| – | +13.0% | +41.9% | -33.9% | -4.2% | -16.3% | -25.9% | -10.6% | -16.4% | -4.4% | -1.3% | +4.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -277.3% | – | +33.5% | -32.3% | -378.8% | – | -126.2% | – | – | – | – | – | |
| – | +446.9% | +43.2% | +86.7% | -16.4% | -81.5% | -78.9% | -100.0% | – | -86.1% | +53.3% | +15.2% | – | |
| – | – | -107.6% | – | +61.6% | -63.1% | +82.1% | -24.4% | -7.2% | -99.9% | +10.3% | -46,662.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -62.6% | +67.7% | -100.0% | – | -102.6% | – | +131.6% | +0.9% | -100.0% | – | – | |
| – | – | -232.4% | – | – | +13.8% | -80.0% | -102.1% | – | -173.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.